[ad_1]
Global endocrine testing market
DUBLIN, April 10, 2024 (GLOBE NEWSWIRE) — “Global Endocrine Testing Market Size, Share and Trend Analysis Report by Test Type (TSH, hCG Hormone), By End-Use (Hospitals, Commercial Laboratories), Added “Technology (Immunoassay, Clinical Testing)” “Chemistry)” and “Segment Forecast, 2024-2030” reports ResearchAndMarkets.com Recruitment.
The global endocrine testing market size is expected to reach USD 21.42 billion by 2030, registering a CAGR of 8.5%
The increasing prevalence of lifestyle-related diseases such as diabetes and thyroid-related obesity not only among adults but also among the elderly population has increased the need for endocrine testing. This awareness towards better health is contributing significantly to the growth of the global endocrine testing market, as regular endocrine testing of an individual helps in maintaining overall health.
According to WHO statistics, more than 39 million children under the age of five were overweight or obese in 2020. A sedentary lifestyle and unhealthy food choices contribute to obesity and diabetes in the general population. The occurrence of such pathologies has also prompted much research into metabolic function and related hormonal disorders.
Funding from governments and private organizations has also motivated the scientific community. For example, NIH’s NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) promotes many sponsored research programs aimed at increasing our understanding of disease and improving health. One such initiative by NIDDK is his September 2022 Mid-Atlantic Symposium for Diabetes and Obesity Research. This enables the exchange and exchange of scientific knowledge and enables cooperation at the regional level. Such efforts will advance the understanding of the endocrine functions of the human body and further enable the growth of the endocrine testing market.
Lack of awareness in underdeveloped and developing countries is expected to slow down the growth of the endocrine testing market. Due to the evolving healthcare environment and lack of reimbursement models, people in these regions have limited access to regular endocrine testing. However, testing frequency is expected to increase in these countries as awareness of healthy systems increases during the COVID-19 pandemic.
The coronavirus disease (COVID-19) outbreak has created favorable opportunities for the application of endocrine testing. COVID-19 causes a systemic disease that damages many organs. Therefore, these patients have many metabolic and hormonal disorders, leading to an increased number of endocrine studies.
Additionally, the travel restrictions and restrictions imposed by the lockdown also facilitated digital platforms for medical consultation and home specimen collection services. The availability of point-of-care devices and kits for detecting hormone levels at home is also driving the growth of the overall endocrine testing market.
Due to various factors that are expected to grow the endocrine testing market, market players are also expanding their presence in the region. Collaboration, partnership and global expansion are some of the business strategies by leading companies to drive revenue generation. For example, in February 2022, Laboratory Corporation of America Holdings (Labcorp) announced the opening of a new laboratory in Indiana, USA. The new diagnostic operation in South Bend, Indiana will enhance the company’s services and make them available to both patients and physicians. In this area.
Endocrine Testing Market Report Highlights
-
By test type, the thyroid stimulating hormone (TSH) testing segment led the market, accounting for the largest revenue share of 28.0% in 2023. The increasing prevalence of thyroid disease and increased awareness of early detection has increased the demand for TSH testing.
-
By technology, tandem mass spectrometry segment accounted for the largest revenue share of 24.5% in 2023. This is because it is often used in conjunction with liquid chromatography and helps to obtain more accurate results.
-
By end-user, private laboratories are estimated to register the fastest CAGR from 2024 to 2030. Outsourcing of diagnostic services, cost-effectiveness, and specialized testing capabilities are contributing to the growth of endocrine testing in private laboratories.
-
North America had the highest revenue in the endocrine testing market in 2023. This is thought to be due to the high prevalence of thyroid disease, diabetes, and obesity within the U.S. population. Additionally, medical developments and increased spending patterns in the region also led to higher revenues.
Company Profile
-
Abbott Laboratories
-
AB Cyex
-
Agilent Technologies Co., Ltd.
-
bioMerieux SA
-
Bio-Rad Laboratories, Inc.
-
Diasolin SpA
-
F. Hoffman La Roche Co., Ltd.
-
Laboratory Corporation of America Holdings
-
Quest Diagnostics Incorporated
-
ortho clinical diagnosis
Key attributes:
|
report attributes |
detail |
|
number of pages |
180 |
|
Forecast period |
2023-2030 |
|
Estimated market value in 2023 (USD) |
$12.19 billion |
|
Projected market value to 2030 (USD) |
$21.42 billion |
|
compound annual growth rate |
8.5% |
|
Target area |
global |
Main topics covered:
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
2.1. Market outlook
2.2. Segment outlook
2.3. Competitive Insights
Chapter 3 Endocrine Testing Market Variables, Trends, and Scope
3.1. Market system outlook
3.1.1. Parent market outlook
3.1.2. Related/Supplementary Market Outlook
3.2. Market trends
3.2.1. Analysis of market drivers
3.2.1.1. Increased prevalence of endocrine diseases
3.2.1.2. Demand for home medical care and increasing awareness of regular examinations
3.2.1.3. Advances in product technology
3.2.1.4. Increased investment in research activities to understand diseases
3.2.2. Market constraint analysis
3.2.2.1. High cost of advanced endocrine testing equipment
3.2.2.2. Lack of awareness in underdeveloped and developing countries
3.3. Endocrine testing market analysis tools
3.3.1. Industry Analysis – Porters
3.3.2. PESTEL analysis
3.3.3. Price analysis
Chapter 4 Endocrine Testing Market: Test Type Estimation and Trend Analysis
4.1. Test Type Market Share, 2023 and 2030
4.2. Segment Dashboard
4.3. Global Endocrine Testing Market Outlook by Test Type
4.4. Market size, forecast and trend analysis from 2018 to 2030
4.4.1. Estradiol (E2) testing
4.4.1.1. Market Forecast and Forecast 2018-2030 (USD Million)
4.4.2. Follicle stimulating hormone (FSH) test
4.4.3. Human chorionic gonadotropin (hCG) hormone test
4.4.4. Luteinizing Hormone (LH) Test
4.4.5. Dehydroepiandrosterone sulfate (DHEAS) test
4.4.6. Progesterone test
4.4.7. Testosterone testing
4.4.8. Thyroid stimulating hormone (TSH) test
4.4.9. Prolactin test
4.4.10. Thyroid stimulating hormone (TSH) test
4.4.11. Cortisol test
4.4.12.insulin test
Chapter 5 Endocrine Testing Market: Technology Forecast and Trend Analysis
5.1. Technology Market Share, 2023 and 2030
5.2. Segment Dashboard
5.3. Global Endocrine Testing Market by Technology Outlook
5.4. Market size, forecast and trend analysis from 2018 to 2030
5.4.1. Tandem mass spectrometry
5.4.1.1. Market Forecast and Forecast 2018-2030 (USD Million)
5.4.2. Immunoassay
5.4.3. Monoclonal and polyclonal antibody technology
5.4.4. Sensor technology
5.4.5. Clinical chemistry
Chapter 6 Endocrine Testing Market: End Use Forecast and Trend Analysis
6.1. End-Use Market Share, 2023 and 2030
6.2. Segment Dashboard
6.3. Global Endocrine Testing Market Outlook by End-Use
6.4. Market size, forecast and trend analysis from 2018 to 2030
6.4.1. Hospital
6.4.1.1. Market Forecast and Forecast 2018-2030 (USD Million)
6.4.2. Commercial Research Institute
6.4.3. Outpatient treatment center
Chapter 7 Endocrine Testing Market: Regional Estimates and Trend Analysis
7.1. Regional Market Share Analysis, 2023 and 2030
7.2. Regional Market Dashboard
7.3. Global regional market snapshot
7.4. Market size and forecast trend analysis from 2018 to 2030
Chapter 8 Competitive Environment
8.1. Recent developments and impact analysis by key market participants
8.2. Company/Competitor Classification
8.3. Vendor landscape
8.3.1. List of major distributors and channel partners
8.3.2. Major customers
8.3.3. Market share analysis of key companies, 2023
For more information on this report, please visit https://www.researchandmarkets.com/r/ychyne.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.
attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
[ad_2]
Source link
